IZIgnacio Zarante

Ignacio Zarante

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ignacio Zarante has a total of 576 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Strengthening Medical Genetics and Genomic Medicine in Colombia: Progress, Challenges, and Strategic Opportunities

    by Paola Liliana Páez Rojas, Lina María Mora, Juan Sebastián Rincón, Ignacio Zarante Montoya, María Camila León-Sanabria, Ana María Urueña-Serrano

    Colombia, an upper-middle-income country with over 52 million inhabitants, has made significant progress in consolidating medical genetics as a clinical specialty, with a growing presence in healthcare system, public health and academia. The development of specialized training programs, the establishment of a professional association, and the inclusion of genetic tests and treatments for rare diseases (RDs) within the health system have been key achievements. Birth defects (BD) remain one of the leading causes of infant morbidity and mortality, and alongside RDs, are recognized as public health priorities. Among regulatory milestones, the Newborn Screening (NBS) Law has strengthened early diagnosis efforts. Nevertheless, operational challenges persist, particularly in the nationwide implementation of genetic services, which remain concentrated in urban centers, creating significant gaps in rural areas. While technologies such as next-generation sequencing (NGS) are increasingly available in the private sector, a persistent fragmentation between molecular diagnosis and clinical care limits their impact. Furthermore, interoperability with health information systems is limited, and the country’s low density of medical geneticists restricts service availability. The Colombian experience underscores the value of institutional coordination, investment in diagnostic infrastructure, and the active role of patient organizations. Despite existing challenges, regional cooperation within Latin America emerges as a strategic opportunity to strengthen medical genetics and expand access for populations affected by RDs and complex genetic conditions.


  • ARTHROGRYPOSIS MULTIPLEX CONGENITA: A CASE-CONTROL STUDY ANALYZING RISK FACTORS FOR NEWBORN PRESENTATION IN BOGOTá AND CALI, COLOMBIA

    by Gabriela Jovel-Trujillo, Esteban Portilla-Rojas, Juliana Lores, Karen Sarmiento, Ignacio Zarante

    Background: Arthrogryposis Multiplex Congenita (AMC) is a rare musculoskeletal birth defect, our objective is to conduct an epidemiological characterization of the prevalence and risk factors associated with the presentation of AMC in newborns. Methods: A population-based case-control study was performed with the data from the Program for the Prevention and Surveillance of Birth Defects and Rare Diseases of Bogotá and Cali (PREVERDEC) from January 2002 to March 2020. Including 29 cases of AMC and 126 controls. Prevalence was calculated per 10,000 Live Births (LB) with a 95% confidence interval. Demographic factors were analyzed using Student’s [ ]-test, and risk factors for AMC were assessed through univariate regression. Results: The prevalence of AMC amounted to 0.52 cases per 10,000 LB (95% CI: 0.35–0.75). Increased association for AMC was found in cases with low birth weight (<2,500 g), low gestational age (35 years, male newborns and folic acid consumption. Conclusion: This study explores the prevalence and risk factors of AMC in Bogotá and Cali, Colombia, aiming to mitigate morbidity in susceptible populations. Establishing surveillance systems for congenital abnormalities is crucial for enhancing AMC identification, diagnosis, and early treatment.

  • Transposition of the great vessels in Bogotá and Cali, Colombia: A current perspective

    by Pablo Pineda-Sanabria, Catalina Arbelaez-Hoyos, Esteban Portilla-Rojas, María Paula Díaz, Edgar Manuel Alvarado, Juan Sebastián Villarraga, Juliana Lores, Karen Sarmiento, Ignacio Zarante

  • Open Access

    Pain, quality of life, and integral management in a cohort of patients diagnosed with hypophosphatasia in Colombia

    by Jorge Armando Rojas Martínez, Ana María Zarante Bahamón, Luz Victoria Salazar, Andrés Felipe Morales, María Fernanda Higuera Cristancho, Juliana Villanueva Congote, Ignacio Zarante Montoya, Lina María Gómez Espitia

    Background: Hypophosphatasia (HPP; OMIM 241510, 241500, and 146300) is a progressive metabolic, genetic disease with wide clinical heterogeneity, ranging from perinatal lethality to mild or moderate localized symptoms. This study aims to analyze the perception of pain, quality of life, and access barriers to healthcare among patients diagnosed with hypophosphatasia in Colombia. In this document we present pain and quality of life results. Methods: This study is an observational cohort of 18 HPP patients registered in the Colombian Association of Patients with Lysosomal Storage Diseases and Other Orphan Diseases (ACOPEL) database. We conducted a descriptive analysis using data from three questionnaires (SF-36, Brief Pain Questionnaire (BPQ), and Hypophosphatasia Impact Patient Survey (HIPS); the latter was translated into Spanish and validated for this study. Results: The most affected features, according to the SF-36 questionnaire, were overall health, vitality, and pain, with a median score above 67%. Patients' perception of their health status (HIPS questionnaire) was favorable, with 38.9% of cases reporting excellent health. On average, results from the BPQ indicated mild to moderate intensity of current pain experienced by patients. Consistency was observed in the reports of either the absence of pain or the presence of mild to moderate intensity when analyzing the results of the three questionnaires. Conclusions: Colombian patients with HPP experience mild to moderate impairment in quality of life and pain that interfere with their daily activities. However, there is wide variability in the results obtained.


  • Open Access

    Panorama de la fenilcetonuria en Colombia

    by Ana Maria Zarante Bahamón, Sandra Milena Navarro Marroquín, Juan Carlos Prieto, Lissete Cabarcas Castro, Marvid Sol Duarte Moreno, Oscar Mauricio Espitia Segura, Ignacio Zarante, Luz Helena Castaño Torres, Sandra Catalina Mesa Restrepo, Carolina Baquero, et al.

    Antecedentes: La fenilcetonuria (PKU), es un error innato del metabolismo secundario a un defecto del metabolismo hepático de la fenilalanina. Su acumulación afecta principalmente el sistema nervioso central, generando discapacidad cognitiva y alteración comportamental importante. Tema: El diagnóstico temprano, mediante el cribado neonatal, permite modificar la historia natural de la enfermedad y brindar un adecuado asesoramiento genético. Conclusión: Los autores damos una revisión al estado actual de la patología y el tamizaje neonatal en Colombia, así como los retos en el seguimiento y manejo de estos pacientes diagnosticados temprana o tardíamente.

  • Open Access

    Moving towards new horizons: the evolution of Universitas Médica

    by Ignacio Zarante, Diana Marcela Achury Saldaña, Favio Andrés Flórez

  • Open Access

    Fenotipificación y genotipificación en pacientes con enfermedad inflamatoria intestinal en un centro de referencia de Colombia

    by Viviana Parra Izquierdo, Albis Cecilia Hani, Consuelo Romero-Sánchez, Ana Isabel Sánchez, Yuly Laguado, Ana María Leguizamó, Juan Sebastián Frías-Ordoñez, Gerardo Andrés Puentes, Ignacio Zarante

    Introduction: Attempts have been made to identify the genetic factors related to susceptibility to inflammatory bowel disease (IBD), and the current conclusions are in favor of a complex pathology model, without a clear hereditary pattern. Objective: To perform phenotypic and genotypic characterization of patients with IBD in Colombian population and to describe its possible association with predisposition. Materials and methods: case series, 16 patients with IBD according to clinical and pathological criteria, onset of gastrointestinal symptoms after 18 years of age. All had pre-test genetic counseling and family trees of at least three generations were made. Also, genotyping, using a multigene panel that included genes related to IBD and some autoimmune disorders. Finally, a genomic analysis of variants was performed. Results: 9 women and 7 men, with mean age of diagnosis of IBD of 35 years, and gastrointestinal symptoms appearance of 32 years. 11/16 (68.75%) required biological therapy. 10/16 (62.5%) were refractory to standard therapy. 3/16 (18.75%) had positive family history of IBD. 100% cases presented at least one single nucleotide polymorphism related to IBD risk in more than one gene. The genes most related to ulcerative colitis (UC) were CD48, CD6, and TYK2 for UC, and CD6 and ITGAM for Crohn's disease. The most frequent gene was CD6. It was found presence of up to 5 genes in 3/16 (18.75%), 4 in 3/16 (18.75%), and three in 5/16 (31.25%). Conclusion: In IBD there is the presence of genetic variants with associated predisposition, but without confirmed pathogenicity, and whose sum seems to contribute to its pathophysiology. Introducción: Se ha tratado de identificar los factores genéticos relacionados con susceptibilidad para enfermedad inflamatoria intestinal (EII), y los hallazgos actuales se inclinan por un modelo de patología complejo, sin un patrón hereditario claro. Objetivo: Realizar caracterización fenotípica y genotípica de pacientes con EII en población colombiana y describir su posible asociación con predisposición. Materiales y métodos: Serie de casos, 16 pacientes con EII por criterios clínicos y anatomopatológicos, inicio de síntomas gastrointestinales después de los 18 años. Todos tuvieron asesoramiento genético pre-test y se realizaron árboles genealógicos de mínimo tres generaciones. También, genotipificación, por medio de un panel de genes múltiples que incluía genes relacionados con EII y algunos trastornos autoinmunitarios. Finalmente, se realizó análisis genómico de variantes. Resultados: 9 mujeres y 7 hombres, con edad media de diagnóstico de EII 35 años, y 32 años para aparición de síntomas gastrointestinales. 11/16(68,75%) requirieron terapia biológica. 10/16 (62,5%) presentaron refractariedad a terapia estándar. 3/16 (18,75%) tenían antecedentes familiares positivos de EII. 100% casos presentaron al menos un single nucleotide polymorphism relacionado con riesgo de EII en más de un gen. Los genes más relacionados con colitis ulcerosa (CU), fueron CD48, CD6, y TYK2 para CU, y CD6 e ITGAM para la enfermedad de Crohn. El gen más frecuente fue CD6. Se observó en 3/16 (18,75%) presencia de hasta 5 genes, 4 en 3/16 (18,75%), y tres en 5/16 (31,25%). Conclusión: En EII hay presencia de variantes genéticas con predisposición asociada, pero sin patogenicidad confirmada, y cuya sumatoria parece contribuir en su fisiopatología


  • Top Cited Papers
    Open Access

    The Human Phenotype Ontology in 2024: phenotypes around the world

    by Michael A Gargano, Nicolas Matentzoglu, Ben Coleman, Eunice B Addo-Lartey, Anna V Anagnostopoulos, Joel Anderton, Paul Avillach, Anita M Bagley, Eduard Bakštein, James P Balhoff, et al.

    The Human Phenotype Ontology (HPO) is a widely used resource that comprehensively organizes and defines the phenotypic features of human disease, enabling computational inference and supporting genomic and phenotypic analyses through semantic similarity and machine learning algorithms. The HPO has widespread applications in clinical diagnostics and translational research, including genomic diagnostics, gene-disease discovery, and cohort analytics. In recent years, groups around the world have developed translations of the HPO from English to other languages, and the HPO browser has been internationalized, allowing users to view HPO term labels and in many cases synonyms and definitions in ten languages in addition to English. Since our last report, a total of 2239 new HPO terms and 49235 new HPO annotations were developed, many in collaboration with external groups in the fields of psychiatry, arthrogryposis, immunology and cardiology. The Medical Action Ontology (MAxO) is a new effort to model treatments and other measures taken for clinical management. Finally, the HPO consortium is contributing to efforts to integrate the HPO and the GA4GH Phenopacket Schema into electronic health records (EHRs) with the goal of more standardized and computable integration of rare disease data in EHRs.


  • Open Access

    Exploring the prevalence of birth defects of the gastrointestinal tract in newborns: A Six-year analysis in Bogotá, Colombia

    by Catalina Correa, Sandra Pastrán, María Camila León-Sanabria, María Paula Aguilera-Pena, José Nieto, Ana María Urueña-S Fgerrano, Ignacio Zarante


  • Open Access

    Asociación poco frecuente del complejo OEIS con un defecto diafragmático

    by Paola Catalina Torres, Lina Paola Montaña-Jiménez, Ayelet Ramirez-Corredor, Yaris Anzully Vargas Vaca, Ignacio Zarante, Ruth Liliana Lopez Cruz

    El complejo OEIS (onfalocele, extrofia cloacal, ano imperforado y defectos espinales) forma parte de los defectos de pared abdominal. Es una entidad infrecuente, que conlleva alta morbimortalidad y requiere de manejo multidisciplinario. Objetivo: Reportar un caso de asociación poco frecuente entre el complejo OEIS y hernia diafragmática; discutir su patogénesis y posible asociación con otras malformaciones de línea media. Caso Clínico: Neonato pretérmino, con diagnóstico antenatal de onfalocele. Al nacer destacó onfalocele gigante con amnios íntegro que contenía todo el hígado y asas, extrofia vesical con vejiga abierta y orificios uretrales expuestos, útero didelfo, epispadias, no se palparon gónadas, mediante imágenes se logró evidenciar extrusión de los tejidos blandos de pelvis, hernia diafragmática izquierda (Bochdalek), malformaciones óseas, mielomeningocele y mielocistocele. Con dichos hallazgos, se planteó complejo OEIS con presentación simultánea de pentalogía Cantrell o deleción 1p36, en el estudio genético se descartaron cromosomopatías, pero no se pudo completar estudio más específico. Se realizó colostomía, cierre de cloaca y afrontamiento a línea media de placa vesical, con adecuada evolución postoperatoria. Dada estabilidad respiratoria, se difirió corrección quirúrgica de hernia diafragmática. Se dio de alta después de una larga hospitalización, falleciendo por patología respiratoria aguda intercurrente. Conclusiones: Dentro de las asociaciones clínicas del complejo OEIS la hernia diafragmática es infrecuente, lo que podría corresponder a una forma inusual del complejo, debido a presentación simultánea con pentalogía Cantrell o deleción 1p36. A pesar de ser una malformación de presentación esporádica, es importante tener conocimien- to de sus características y variantes.